Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children

Journal of Autoimmunity

Volumn 11, Issue 6, 1998, Pages 643-650

  Yamamoto, Ana M ^a   Deschamps, Ingebold ^a   Garchon, Henri Jean ^a   Roussely, Hughette ^a   Moreau, Nathalie ^a   Beaurain, Geneviève ^b   Robert, Jean Jacques ^a   Bach, Jean François ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Age; Autoantibodies; GAD; HLA DR3 4; IA 2; IAA; ICA; Prediction; Type 1 (insulin dependent) diabetes mellitus

Indexed keywords

HLA DR ANTIGEN; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; AGE; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHILD; FEMALE; GENETIC RISK; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIBLING;

EID: 0032432402     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0244     Document Type: Article

References (28)

1. Atkinson M.A., Maclaren N.K. The pathogenesis of insulin-dependent diabetes mellitus. N. Eng. J. Med. 331:1994;1428-1436.
2. Eisenbarth, G.S. Lafferty, K.J. 1996, Type I Diabetes, Oxford University Press, Oxford.
3. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science. 222:1983;1337-1339.
4. Bonifacio E., Bingley P.J., Shattock M., Dean B.M., Dunger D., Gale E.A., Bottazzo G.F. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet. 335:1990;147-1495.
5. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., Decamilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 347:1990;151-156.
6. Rabin D.U., Pleasic S.M., Shapiro J.A., Yoo-Warren H., Oles J., Hicks J.M., Goldstein D.E., Rae P.M. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J. Immunol. 152:1994;3183-3188.
7. Bonifacio E., Lampasona V., Genovese S., Ferrari M., Bosi E. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J. Immunol. 155:1995;5419-5426.
8. Lan M.S., Wasserfall C., MacLaren N.K., Notkins A.L. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA. 93:1996;6367-6370.
9. Schott M., Schatz D., Atkinson M., Krischer J., Mehta H., Vold B., Maclaren N. GAD65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus. J. Autoimmunity. 7:1994;865-872.
10. Bingley P.J., Christie M.R., Bonifacio E., Bonfanti R., Shattock M., Fonte M.T., Bottazzo G.F., Gale E.A. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes. 43:1994;1304-1310.
11. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase H.P., Eisenbarth G.S. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes. 45:1996;926-933.
12. +. Diabetes. 45:1996;1720-1728.
13. Bonifacio E., Genovese S., Braghi S., Bazzigaluppi E., Lampasona V., Bingley P.J., Rogge L., Pastore M.R., Bognetti E., Bottazzo G.F., Gale E.A.M., Bosi E. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia. 38:1995;816-822.
14. Gorus F.K., Goubert P., Semakula C., Vandewalle C.L., de Schepper J., Scheen A., Christie M.R., Pipeleers D.G. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Diabetologia. 40:1997;95-99.
15. Thivolet C., Beaufrère B., Geburher L., Chatelain P., Orgiazzi J., François R. Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients. Diabetologia. 34:1991;186-191.
16. Vandewalle C.L., Falorni A., Lernmark A., Goubert P., Dorchy H., Coucke W., Semakula C., Van Der Auwera B., Kaufman L., Schuit F.C., Pipeleers D.G., Gorus F.K. Associations of GAD65-and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. Diabetes Care. 20:1997;1547-1552.
17. Christie M.R., Roll U., Payton M.A., Hatfield E.C., Ziegler A.G. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care. 20:1997;965-970.
18. Roll U., Ziegler A.G. Combined antibody screening for improved prediction of IDDM-modern strategies. Exp. Clin. Endocrinol. Diabetes. 105:1997;1-14.
19. Wiest-Ladenburger U., Hartmann R., Hartmann U., Berling K., Bohm B.O., Richter W. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test. Diabetes. 46:1997;565-571.
20. Kulmala P., Savola K., Petersen J.S., Vahasalo P., Karjalainen J., Lopponen T., Dyrberg T., Akerblom H.K., Knip M. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. J. Clin. Invest. 101:1998;327-336.
21. Verge C.F., Gianani R., Kawasaki E., Yu L., Pictropaolo M., Chase H.P., Eisenbarth G.S. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J. Autoimmunity. 9:1996;379-383.
22. Bottazzo G.F., Christensen F.A., Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency. Lancet. 2:1974;1279-1283.
23. Bonifacio E., Boitard C., Gleichmann H., Shattock M.A., Molenaar J.L., Bottazzo G.F. Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays. Diabetologia. 31:1990;597-602.
24. Petersen J.S., Hejnaes K.R., Moody A., Karlsen A.E., Marshall M.O., Hoier-Madsen M., Boel E., Michelsen B.K., Dyrberg T. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes. 43:1994;459-467.
25. Ziegler A.G., Ziegler R., Vardi P., Jackson R.A., Soeldner J.S., Eisenbarth G.S. Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes. 38:1989;1320-1325.
26. Robert J.J., Deschamps I., Chevenne D., Roger M., Mogenet A., Boitard C. Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type I diabetes in 220 juvenile first-degree relatives of diabetic patients. Diabetes Care. 14:1991;718-723.
27. Deschamps I., Lestradet H., Busson M., Hors J. Effects of HLA genotype, age and birth order on empirical risk estimates for insulin-dependent diabetes in siblings of diabetic children. An actuarial evaluation. Diabetes Res. 3:1986;391-396.
28. Riley W.J., MacLaren N.K., Krischer J., Spillar R.P., Silverstein J.H., Schatz D.A., Schwartz S., Malone J., Shah S., Vadheim C., Rotter J.I. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N. Engl. J. Med. 323:1990;1167-1172.